Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garrett M Brodeur

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Cancer Research|November 20, 2002
Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13John M Maris, Matthew J Weiss, Yael Mosse, et al.
Cancer Letters|January 23, 2016
Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse modelRadhika Iyer, Lea Wehrmann, Rebecca L Golden, et al.
Pediatric Blood & Cancer|June 23, 2018
Diagnosis of Beckwith-Wiedemann syndrome in children presenting with Wilms tumorSuzanne P MacFarland, Kelly A Duffy, Tricia R Bhatti, et al.
American Journal of Medical Genetics. Part A|March 28, 2024
Developmental and behavioral phenotypes of pediatric patients with PTEN hamartoma tumor syndromeSuzanne P MacFarland, Melani Duvall, Raissa Tchetcho Kemajou, et al.
Journal of the National Cancer Institute|June 26, 2008
CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomasTomoyuki Fujita, Jun Igarashi, Erin R Okawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2024
Neuroblastoma Predisposition and Surveillance-An Update from the 2023 AACR Childhood Cancer Predisposition WorkshopJunne Kamihara, Lisa R Diller, William D Foulkes, et al.
Oncology Reports|April 23, 2020
RET receptor expression and interaction with TRK receptors in neuroblastomasLaura H Tetri, Venkatadri Kolla, Rebecca L Golden, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2011
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium studyJane E Minturn, Audrey E Evans, Judith G Villablanca, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 24, 2022
Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer PredispositionSuzanne P MacFarland, Luke Maese, Surya P Rednam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force reportSusan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Cancer Research|November 20, 2002
Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13John M Maris, Matthew J Weiss, Yael Mosse, et al.
Cancer Letters|January 23, 2016
Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse modelRadhika Iyer, Lea Wehrmann, Rebecca L Golden, et al.
Pediatric Blood & Cancer|June 23, 2018
Diagnosis of Beckwith-Wiedemann syndrome in children presenting with Wilms tumorSuzanne P MacFarland, Kelly A Duffy, Tricia R Bhatti, et al.
American Journal of Medical Genetics. Part A|March 28, 2024
Developmental and behavioral phenotypes of pediatric patients with PTEN hamartoma tumor syndromeSuzanne P MacFarland, Melani Duvall, Raissa Tchetcho Kemajou, et al.
Journal of the National Cancer Institute|June 26, 2008
CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomasTomoyuki Fujita, Jun Igarashi, Erin R Okawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2024
Neuroblastoma Predisposition and Surveillance-An Update from the 2023 AACR Childhood Cancer Predisposition WorkshopJunne Kamihara, Lisa R Diller, William D Foulkes, et al.
Oncology Reports|April 23, 2020
RET receptor expression and interaction with TRK receptors in neuroblastomasLaura H Tetri, Venkatadri Kolla, Rebecca L Golden, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2011
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium studyJane E Minturn, Audrey E Evans, Judith G Villablanca, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 24, 2022
Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer PredispositionSuzanne P MacFarland, Luke Maese, Surya P Rednam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force reportSusan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Pageof 9